Moderna, IBM to use quantum computing, AI for mRNA research
Tim Boyle


Moderna (NASDAQ:MRNA) has signed an agreement with IBM (NYSE:IBM) to use technologies including quantum computing and artificial intelligence to advance mRNA research.
The companies define quantum computing as utilizing "the principles of quantum mechanics to solve problems too complex for classical computers."

Moderna (MRNA) will take part in the IBM Quantum Accelerator program and the IBM Quantum Network. IBM (IBM) will provide access to quantum computing systems.
Also, scientists from both companies will tap MoLFormer, "an AI foundation model that can help scientists predict a molecule's properties, and could help them understand the characteristics of potential mRNA medicines."
Moderna's (MRNA) aim is to use this technology to optimize lipid nanoparticles that encapsulate mRNA as it goes through the body, and mRNA, which provides instructions to cells to fight disease.
Seeking Alpha's Quant Rating views Moderna (MRNA) as a hold.